Childhood refractory autoimmune haemolytic anaemia: Is there a role for anti-CD20 therapy (rituximab)?

Authors :: Mc Mahon, C
Babu, L
Hodgson, A
Hayat, A
Connell, N. O
Smith, O. P
Source :: British Journal of Haematology; May2002, Vol. 117 Issue 2, p480-483, 2p, 2 Graphs
Publication Year :: 2002
Abstract: Reports on the case of a pediatric patient with relapsed refractory autoimmune hemolytic anemia. Medical history of the patient; Outcome of treatments with rituximab or anti-CD20 antigen therapy; Recommendation to prevent opportunistic infections.

Subjects :: AUTOIMMUNE hemolytic anemia
ANEMIA in children
CD antigens
THERAPEUTICS

Full Text Access

Tools